Volume 25, Number 2—February 2019
Synopsis
Trends of Human Plague, Madagascar, 1998–2016
Table 1
Clinical form | Microscopy, 1998–2001 |
F1RDT, 2002–2008 |
|||
---|---|---|---|---|---|
Sensitivity | Specificity | Sensitivity | Specificity | ||
Bubonic | 34% (31%–38%) | 96% (95%–97%) | 100% (99%–100%) | 60% (58%–62%) | |
Pneumonic |
53% (34%–71%) |
94% (84%–98%) |
100% (90%–100%) |
45% (37%–52%) |
|
Total | 35% (32%–39%) | 96% (95%–97%) | 100% (99%–100%) | 59% (57%–61%) |
*Values in parentheses are ranges. Bacteriological culture was used as a reference test. F1RDT, Yersinia pestis antigen fraction 1 rapid diagnostic test.
1These authors contributed equally to this article.
2Current affiliation: Institut Pasteur, Phnom Penh, Cambodia.
3Retired.
4Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Page created: January 18, 2019
Page updated: January 18, 2019
Page reviewed: January 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.